3971-28-6Relevant articles and documents
Cis-Dichlorido(3,6,9-trithiabicyclo[9.3.1]pentadecane-κ2 S 3,S 6)palladium(II) acetonitrile 0.8-solvate
Dawe, Louise Nicole,Penney, Lisa,Black, Daniel A.,Miller, David O.,Lucas, C. Robert
, p. 727 - 729 (2013)
In the title complex, [PdCl2(C12H22S 3)]·0.8CH3CN, a potentially tridentate thioether ligand coordinates in a cis-bidentate manner to yield a square-planar environment for the PdII cation [mean deviation of the Pd from the Cl2S2 plane = 0.0406 (7) A]. Each square-planar entity packs in an inverse face-to-face manner, giving pairs with plane-to-plane separations of 3.6225 (12) A off-set by 1.1263 (19) A, with a Pd...Pd separation of 3.8551 (8) A. A partial acetonitrile solvent molecule is present. The occupancy of this molecule was allowed to refine, and converged to 0.794 (10). The synthesis of the previously unreported 3,6,9-trithiabicyclo[9.3.1]pentadecane ligand is also outlined.
GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 001540; 001541; 00154; 002261; 002262; 002264, (2019/07/17)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
METHOD FOR PREPARING 1,3-CYCLOHEXANEDIMETHANOL
-
Paragraph 00057-0071, (2019/07/15)
The present invention relates to a method for preparing high-purity 1,3-cyclohexanedimethanol capable of achieving a high conversion rate by allowing most of the reactant to participate in the reaction, and of increasing reaction efficiency and economic efficiency by further simplifying the reaction process, while minimizing by-products within a shorter period of time. Specifically, the method for preparing 1,3-cyclohexanedimethanol includes reducing 1,3-cyclohexanedicarboxylic acid in the presence of a metal catalyst, which is fixed to a silica support and includes a ruthenium (Ru) compound, a tin (Sn) compound and a platinum (Pt) compound in a weight ratio of 1:0.8 to 1.2:1.2 to 2.4.